Cargando…
Endoscopic Lung Volume Reduction: Review of the EMPROVE and LIBERATE trials
Endoscopic lung volume reduction is now included in the guidelines for treatment in severe chronic obstructive pulmonary disease. Since December 2018, 2 valve systems have been approved by the US Food and Drug Administration (FDA). To date, there is no head-to-head trial comparing both valve systems...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930786/ https://www.ncbi.nlm.nih.gov/pubmed/33718791 http://dx.doi.org/10.1016/j.mayocpiqo.2020.09.009 |